Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats

Journal of Endocrinology

Volumn 200, Issue 3, 2009, Pages 331-346

  Almon, Richard R ^a   DuBois, Debra C ^a   Lai, William ^a   Xue, Bai ^a   Nie, Jing ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A2; BILIVERDIN; CD14 ANTIGEN; CELLULAR REPRESSOR OF E1A STIMULATED GENE 1; CRYSTALLIN; CXCL14 CHEMOKINE; EPOXIDE HYDROLASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLYCOPROTEIN; INSULIN; INTERFERON; MYOTUBULARIN RELATED PROTEIN 7; NEUROENDOCRINE SPECIFIC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE; RAB PROTEIN; REGULATOR PROTEIN; STAT3 PROTEIN; SULFOTRANSFERASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; GENE EXPRESSION; GENETIC TRANSCRIPTION AND TRANSLATION; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; HYPERGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER; LIVER WEIGHT; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WISTAR KYOTO RAT;

AGING; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; ORGAN SIZE; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION;

EID: 67449114009     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0404     Document Type: Article

References (63)

1. Almind K, Delahaye L, Hansen T, Van Obberghen E, Pedersen O & Kahn CR 2002 Characterization of the Met326lle variant of phosphatidylinositol 3-kinase p85a. PNAS 99 2124-2128.
2. Almon RR, DuBois DC, Jin JY & Jusko WJ 2005a Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle. Journal of Endocrinology 184 219-232.
3. Almon RR, Lai W, DuBois DC & Jusko WJ 2005 b Corticosteroid-regulated genes in rat kidney: mining time series array data. American Journal of Physiology. Endocrinology and Metabolism 289 E870-E882.
4. Almon RR, DuBois DC & Jusko WJ 2007a A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. Endocrinology 148 2209-2225.
5. Almon RR, DuBois DC, Yao Z, Hoffman EP, Ghimbovschi S & Jusko WJ 2007 b Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiological Genomics 30 282-299.
6. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B & Ferrieres J 2008 Energy intake is associated with endotoxemia. American Journal of Clinical Nutrition 87 1219-1223.
7. Bauer M, Hamm AC, Bonaus M, Jacob A, Jaekel J, Schorle H, Pankratz MJ & Katzenberger JD 2004 Starvation response in mouse liver shows strong correlation with life-span-prolonging processes. Physiological Genomics 17 230-244.
8. Bloomgarden ZT 2003 Pharmacologic treatment of type 2 diabetes. Diabetes Care 26 526-533.
9. Bloomquist BT, Darlington DN, Mueller GP, Mains RE & Eipper BA 1994 Regulated endocrine-specific protein-18: a short-lived novel glucocorticoid-regulated endocrine protein. Endocrinology 135 2714-2722.
10. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pfeffer K & Howard JC 1998 Two families of GTPases dominate the complex cellular responses to INF-gamma. Journal of Immunology 161 6715-6723.
11. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C et al. 2007 Metabolic endotoxemia intiates obesity and insulin resistance. Diabetes 56 1761-1772.
12. De Caterina R & Basta G 2001 n-3 Fatty acids and the inflammatory response-biological background. European Heart Journal 3 D42-D49.
13. Clore JN, Post EP, Bailey DJ, Nestler JE & Blackard WG 1992 Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 74 660-666.
14. Cohen P & Goedert M 2004 GSK3 inhibitors: development and therapeutic potential. Nature Reviews. Drug Discovery 3 479-487.
15. Degenhardt T, Matilainen M, Herzig K, Dunlop TW & Carlberg C 2006 The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors. Journal of Biological Chemistry 281 39607-39619.
16. Dutta R, Singh U, Li TB, Fornage M & Teng BB 2003 Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and apobec1 genes. Atherosclerosis 169 51-62.
17. Gastaldelli A, Baldi S, Pettiti E, Camastra S, Natali A, Landau BR & Ferrannini E 2000 Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans. Diabetes 49 1367-1373.
18. Green CB, Douris N, Kojima S, Strayer CA, Fogerty J, Lourim D, Keller SR & Besharse JC 2007 Loss of nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. PNAS.
19. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR et al. 2000 Mechanism by which metaformin reduces glucose production in type 2 diabetes. Diabetes 49 2063-2069.
20. Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai G, Hansen W, Iwamoto Y, Pober JS, Flavell RA & Fu X 2003 Endothelial cells require STAT3 for protectin against endotoxin-induced inflammation. Journal of Experimental Medicine 198 1517-1525.
21. Kawai M, Bandiera SM, Chang TKH & Bellward GD 2000 Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2. Biochemical Pharmacology 59 1277-1287.
22. Kobayashi T, Zadravec D & Jacobsson A 2007 ELOVL2 overexpression enhances triacylglycerol syntesis in 3T3-L1 and F442A cells. FEBS Letters 581 3157-3163.
23. Kubota K, Kim JY, Sawada A, Tokimasa S, Fujisaki H, Matsuda-Hashii Y, Ozono K & Hara J 2004 LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins. FEBS Letters 564 147-152.
24. Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G & Zeldin DC 2006 Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the aterosclerosis risk communities (ARIC) study. Human Molecular Geneticsv 15 1640-1649.
25. Li Z, Soloski MJ & Diehl AM 2005 Dietary factors alter hepatic innate immune system in mice with nonalcholic fatty liver disease. Hepatology 42 880-885.
26. Lindner I, Rubin D, Helwig U, Nitz I, Hampe J, Schreiver S, Schrezenmeir J & Doring F 2006 The L513S polymorphism in meium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population. Molecular Nutrition & Food Research 50 270-274.
27. Linton MF & Fazio S 2003 Macrphages, inflammation, and atherosclerosis. International Journal of Obesity 27 S35-S40.
28. Lonardo A, Lombardini S, Ricchi M, Scaglioni F & Loria P 2005 Hepatic steatosis and insulin resistance. Alimentary Pharmacology and Therapeutics 22 64-70.
29. Maritano D, Surgue ML, Tininini S, Dewilde S, Strobl B, Fu XP, Murray-Tait V, Chiarle R & Poli V 2004 The STAT3 isoforms A and B have unique and specific functions. Nature Immunology 5 401-409.
30. Matsumoto M, Ogawa W, Akimoto K, Inoue H, Miyake K, Furukawa K, Hayashi Y, Iguchi H, Matsuki Y, Hiramatsu R et al. 2003 PKC in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. Journal of Clinical Investigation 112 935-944.
31. Matsumura T, Semba K, Azuma S, Ikawa S, Gohda J, Akiyama T & Inoue J 2004 TIFAB inhibits TIFA, TRAF-interacting protein with a forkhead associated domain. Biochemical and Biophysical Research Communications 317 230-234.
32. Meuter S, Schaerli P, Roos RS, Brandau O, Bosl MR, von Andrian UH & Moser B 2007 Murine CXCL1 is dispensable for dendritic cell function and localization within peripheral tissues. Molecular and Cellular Biology 27 983-992.
33. Mochizuki Y & Majerus PW 2003 Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. PNAS 100 9768-9773.
34. Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, Devergie B, Demontis R & Cadranel J-F 2002 Diabetes mellitus during interferon therapy for chronic viral hepatitis. Digestive Diseases and Sciences 47 1649-1654.
35. Morikawa J, Nishimura Y, Uchida A & Tanaka T 2001 Molecular cloning of novel mouse and human putative citrate lyase B-subunit. Biochemical and Biophysical Research Communications 289 1282-1286.
36. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, Muraoka M, Tanaka K, Taya C, Shitara H, Ishii R et al. 2007 Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. Journal of Biological Chemistry 282 30794-30803.
37. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG et al. 2005 Molecular determinants of crosstalk between nuclear receptors and toll-like receptors Cell 122 707-721.
38. O'Rourke. CM, Davis JA, Saltiel AR & Cornicelli JA 1997 Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin dependent diabetes melhtus. Metabolism 46 192-196.
39. Portha B 2005 Programmed disorders of B-cell development and function as one cause for type 2 diabetes? The GK rat paradigm Diabetes/ Metabolism Research and Reviews 21 495-504.
40. Prando R, Cheli V, Melga P, Giusti R, Ciuchi E & Odetti P 1998 Is type 2 diabetes a different disease in obese and nonobese patients? Diabetes Care 21 1680-1685.
41. Ragolia L, Plaia T, Koutrouby TB & Maesaka JK 2004 Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki rats. American Journal of Physiology. Cell Physiology 287 C1273-C1281.
42. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, Maher SL, Brown R, Teasdale RD, Noakes PG & Waters MJ 2005 In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Molecular and Cellular Biology 25 66-77.
43. Sato K, Emi M, Ezura Y, Fujita Y, Ishigami T, Xin Y, Wu L & Larrinaga-Shum S 2004 Soluble epoxide hyrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. Journal of Human Genetics 47 29-34.
44. Schiller MR, Mains RE & Eipper BA 1995 A neuroendocrine-specific protein localized to the endoplasmic reticulum by distal degradation. Journal of Biological Chemistry 270 26129-26138.
45. Sedova L, Seda O, Kazdova L, Chylikova B, Hamet P, Tremblay J, Kren V & Krenova D 2007 Sucrose feeding during pregnancy and lactation elicts distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. American Journal of Physiology. Endocrinology and Metabolism 292 E1318-E1324.
46. Sheth P, Santos ND, Seth A, LaRusso NF & Rao RK 2007 Lipoplysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. American Journal of Physiology Gastrointestinal and Liver Physiology 293 G308-G318.
47. Shu F, Lu S, Qin Y, Ma X, Wang X, Peng X, Luo Y, Xu B, Sun, X & Wu J 2007 Functional characterization of human PFTK1 as a cyclin-dependent kinase. PNAS 104 9248-9253.
48. Suzuki S, Mori J & Hashizume K 2007 mu-Crystallin, a NADPH-dependent t(3)-binding protein in cytosol. Trends in Endocrinology and Metabolism 18 286-289.
49. Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL & Klaassen CD 2008 NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. Journal of Pharmacology and Experimental Therapeutics 325 655-664.
50. Thomson DM, Herway ST, Fillmore N, Kim H, Brown JD, Barrow JR & Winder WW. 2008 AMP-activated protein kinase phosphorylates transcription factors of the CREB family. Journal of Applied Physiology 104 429-438.
51. Tsuchiya T, Dhahbi JM, Cui X, Mote PL, Bartke A & Spindler SR 2004 Additive regulation of hepatic gene expression by dwarfism and caloric restriction. Physiological Genomics 17 307-315.
52. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC & Kahn CR 2003 Positive and negative roles of p85a and p85B regulatory subunits of phospoinositide 3-kinase in insulin signaling. Journal of Biological Chemistry 278 48453-48466.
53. Uyttendaele I, Lemmens I, Verhee A, De Smet A-S, Vandekerckhove J, Lavens D, Peelman F & Tavernier J 2007 Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone reception. Molecular Endocrinology 21 2821-2831.
54. Vallance-Owen J 1952 Liver glycogen in diabetes mellitus. Journal of Clinical Pathology 5 42-53.
55. Veal E, Eisenstein M, Tseng ZH & Gill G 1998 A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Molecular and Cellular Biology 18 5032-5041.
56. Vermna M, Berthiaume F, Jayaraman A & Yarmush ML 2004 Expression profiling analysis of the metabolic and inflammatory changes following burn injury in rats. Physiological Genomics 18 87-98.
57. Wang J & Ortiz de Montellano PR 2003 The binding sites on human heme oxygenase-1 for cytochrome P450 reductase and biliberdin reductase. Journal of Biological Chemistry 278 20069-20076.
58. Wellen KE & Hotamisligil GS 2005 Inflammation, stress, and diabetes. Journal of Clinical Investigation 115 1111-1119.
59. Weng W & Breslow JL 1996 Dramatically decreased high density lipoprotein cholesterol, increased renmant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein in atherosclerosis susceptibility. PNAS 93 14788-14794.
60. Wilson WA, Skurat AV, Probst B, Paoli-Roach A, Roach PJ & Rutter J 2005 Control of mammalian glycogen synthase by PAS kinase. PNAS 102 16596-16601.
61. Wilton JC & Matthews GM 1996 Polarised membrane traffic in hepatocytes. BioEssays 18 229-236.
62. Yan W & Chen X 2006 GPX2, a direct target of p63 inhibits oxidative stress-induced apoptosis in a p53-dependent manner. Journal of Biological Chemistry 281 7856-7862.
63. Yang SQ, Lin HZ, Lane MD, Clemens M & Diehl AM 1997 Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. PNAS 94 2557-2562.